AU2005322617A1 - Immunoglobulins comprising predominantly a Ga1G1cNAcMan5GlcNAc2 glycoform - Google Patents

Immunoglobulins comprising predominantly a Ga1G1cNAcMan5GlcNAc2 glycoform Download PDF

Info

Publication number
AU2005322617A1
AU2005322617A1 AU2005322617A AU2005322617A AU2005322617A1 AU 2005322617 A1 AU2005322617 A1 AU 2005322617A1 AU 2005322617 A AU2005322617 A AU 2005322617A AU 2005322617 A AU2005322617 A AU 2005322617A AU 2005322617 A1 AU2005322617 A1 AU 2005322617A1
Authority
AU
Australia
Prior art keywords
composition
glycan
immunoglobulins
glycans
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005322617A
Other languages
English (en)
Inventor
Tillman U. Gerngross
Huijuan Li
Stefan Wildt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glycofi Inc
Original Assignee
Glycofi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycofi Inc filed Critical Glycofi Inc
Publication of AU2005322617A1 publication Critical patent/AU2005322617A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2005322617A 2004-12-23 2005-07-19 Immunoglobulins comprising predominantly a Ga1G1cNAcMan5GlcNAc2 glycoform Abandoned AU2005322617A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63969804P 2004-12-23 2004-12-23
US63965704P 2004-12-23 2004-12-23
US60/639,698 2004-12-23
US60/639,657 2004-12-23
PCT/US2005/025663 WO2006071280A1 (en) 2004-12-23 2005-07-19 Immunoglobulins comprising predominantly a ga1g1cnacman5glcnac2 glycoform

Publications (1)

Publication Number Publication Date
AU2005322617A1 true AU2005322617A1 (en) 2006-07-06

Family

ID=36084254

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005322617A Abandoned AU2005322617A1 (en) 2004-12-23 2005-07-19 Immunoglobulins comprising predominantly a Ga1G1cNAcMan5GlcNAc2 glycoform

Country Status (5)

Country Link
EP (1) EP1831256A1 (de)
JP (1) JP2008525440A (de)
AU (1) AU2005322617A1 (de)
CA (1) CA2590441A1 (de)
WO (1) WO2006071280A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449308B2 (en) 2000-06-28 2008-11-11 Glycofi, Inc. Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
US7332299B2 (en) 2003-02-20 2008-02-19 Glycofi, Inc. Endomannosidases in the modification of glycoproteins in eukaryotes
WO2007084926A2 (en) 2006-01-17 2007-07-26 Biolex Therapeutics, Inc. Compositions and methods for humanization and optimization of n-glycans in plants
EP2068927B1 (de) 2007-05-14 2015-10-21 MedImmune, LLC Verfahren zur reduzierung eosinophiler spiegel
CN102333872B (zh) * 2009-02-25 2014-07-09 默沙东公司 在糖工程化的酵母巴斯德毕赤酵母中对半乳糖同化途径的代谢工程化
WO2014004549A2 (en) 2012-06-27 2014-01-03 Amgen Inc. Anti-mesothelin binding proteins
JP2018535655A (ja) 2015-09-29 2018-12-06 アムジエン・インコーポレーテツド Ａｓｇｒ阻害剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2558160T3 (es) * 1998-12-09 2016-02-02 Phyton Holdings, Llc Glicoproteínas que tienen glicosilación de tipo humano
WO2002057468A2 (en) * 2001-01-19 2002-07-25 The Dow Chemical Company Method for secretory production of glycoprotein having human-type sugar chain using plant cell
US7507573B2 (en) * 2003-11-14 2009-03-24 Vib, Vzw Modification of protein glycosylation in methylotrophic yeast

Also Published As

Publication number Publication date
WO2006071280B1 (en) 2006-08-17
WO2006071280A1 (en) 2006-07-06
EP1831256A1 (de) 2007-09-12
CA2590441A1 (en) 2006-07-06
JP2008525440A (ja) 2008-07-17

Similar Documents

Publication Publication Date Title
US20060034830A1 (en) Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform
US20060034828A1 (en) Immunoglobulins comprising predominantly a GlcNAcMAN5GLCNAC2 glycoform
US20060034829A1 (en) Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform
US20060029604A1 (en) Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform
US20060024292A1 (en) Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform
US20060024304A1 (en) Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform
US20060257399A1 (en) Immunoglobulins comprising predominantly a Man5GIcNAc2 glycoform
AU2005269759A1 (en) Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform
AU2005269763A1 (en) Immunoglobulins comprising predominantly a Gal2GlcNac2Man3GlcNac2 glycoform
WO2006071856A2 (en) Immunoglobulins comprising predominantly a man5glcnac2 glycoform
AU2005269765A1 (en) Immunoglobulins comprising predominantly a Man3GlcNAc2 glycoform
US20090226464A1 (en) Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform
WO2007028144A2 (en) Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform
AU2005322617A1 (en) Immunoglobulins comprising predominantly a Ga1G1cNAcMan5GlcNAc2 glycoform
AU2005269712A1 (en) Immunoglobulins comprising predominantly a GlcNAcMan5GlcNAc2 glycoform
AU2005269713A1 (en) Immunoglobulins comprising predominantly a Man5GlcNac2 glycoform
CN101001875A (zh) 主要包含man5glcnac2糖形的免疫球蛋白
CN101001876A (zh) 包含占优势的GlcNacMAN5GLCNAC2糖形的免疫球蛋白

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period